At Syngenta's General Shareholders’ Meeting, Dr. Eveline Saupper, member of the Board of Directors since 2013, stepped down as an Independent Director. Dr. Sophie Kornowski was newly elected to the Board as an Independent Director.
Basel/Switzerland — Dr. Kornowski, a French citizen, served as Executive Vice-President of Roche Partnering and was a member of the Roche Extended Corporate Executive Committee as well as a member of the board of Chugai. Later in the year, Kornowski will be joining a major healthcare investment fund headquartered in Cambridge, Massachusetts, as its Senior Partner. Before joining Roche in 2007, Dr. Kornowski held several management positions at Merck Sharp & Dome, Sanofi Winthrop and Abbott Diagnostics and Abbott Pharmaceutical Products. She holds a Doctorate in pharmacy from the Faculty of Pharmacy at Paris V, and an MBA from the University of Chicago Booth, Graduate School of Business.